Biotech

All Articles

Pfizer takes $230M attacked after axing neglected DMD genetics therapy

.Pfizer's stage 3 Duchenne muscular dystrophy (DMD) genetics treatment breakdown has actually gone a...

AC Immune observes 'site' prospective in Alzheimer's medicine information

.After more than 20 years of focus on neurodegenerative ailments, Swiss biotech air conditioning Inv...

GSK drops ph. 2 HPV vaccination over lack of best-in-class potential

.GSK has junked a phase 2 human papillomavirus (HPV) vaccination coming from its pipeline after choo...

OS Therapies refiles $6M IPO to money HER2 medicine, preclinical ADCs

.Operating system Therapies are going to note on the NYSE American stock exchange today using a $6.4...

ALX's waning CD47 reaction cost sends stock spiraling down

.ALX Oncology's period 2 stomach cancer feedback price has weakened. After viewing its CD47 blocker ...

Ionis axes eye disease from intendeds of Roche-partnered possibility after records disappoint

.One More of Ionis Pharmaceuticals' vital midphase readouts has actually disappointed expectations, ...

Biogen's CEO claimed no high-risk handle 2023. He prepares to be strong

.While Biogen's pharma peers are actually searching for late-stage assets with little bit of threat,...

Instil refills pipe in $2B biobucks handle ImmunOnco

.Instil Biography has actually been a biotech trying to find a pipeline after it ditched its own lea...

Biogen walks away from Denali Alzheimer's collab

.Biogen has handed back liberties to a very early Alzheimer's illness plan to Denali Therapies, goin...

Takeda taps brand new head of US oncology organization-- Chutes &amp Ladders

.Invite to recently's Chutes &amp Ladders, our roundup of considerable leadership hirings, firings a...